MMS Holdings Expert Insights Blog

Experts at MMS share their insights on trending
topics in the pharmaceutical industry.

A Recap of 2022’s Orphan Drug Approvals

A Recap of 2022’s Orphan Drug Approvals

In the US, a rare disease is defined as one that affects less than 200,000 people. While these specific diseases are considered rare, living with a rare disease is not. In the US alone, over 30 million people are living with 7,000 different types of rare diseases.1 A...

read more
MMS Logo
6880 Commerce Blvd.
Canton, MI 48187 USA
734.245.0310 T
734.245.0320 F

LinkedIn LogoFacebook logoTwitter logoYoutube logo